JIPOAd
PARP
ESID
  • Users Online: 762
  • Print this page
  • Email this page

    Article Cited by others

REVIEW ARTICLE

Extracellular signal-regulated kinase (ERK) inhibitors in oncology clinical trials

Chin Haelee M, Lai David K, Falchook Gerald S

Year : 2019| Volume: 2| Issue : 1 | Page no: 10-16

   This article has been cited by
 
1 Optimizing Precision Oncology and Immunotherapy Strategies: Moving into the Next Stage of Cancer Medicine
Phoebe Lewis,TimothyA Yap
Journal of Immunotherapy and Precision Oncology. 2019; 2(1): 1
[Pubmed]  [Google Scholar] [DOI]
2 Development of ERK1/2 inhibitors as a therapeutic strategy for tumour with MAPK upstream target mutations
Miao Longfei,Hongqi Tian
Journal of Drug Targeting. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]

 

Read this article